上海外高桥集团股份有限公司（以下简称"公司"）于2025年7月21日召开第十一届董事会第十三次会 议、第十一届监事会第七次会议，审议通过了《关于使用暂时闲置募集资金进行现金管理的议案》，同 意公司在不影响募集资金投资项目建设需要，且不影响公司正常生产经营及确保相关资金安全的前提 下，使用最高不超过50,300万元的闲置募集资金进行现金管理，购买安全性高、流动性好的保本型理财 产品或存款类产品，使用期限自董事会审议通过之日起12个月内有效，在决议有效期内，上述额度可以 循环滚动使用。保荐人对公司使用暂时闲置募集资金进行现金管理的事项无异议。具体内容详见公司于 2025年7月22日披露的《关于使用暂时闲置募集资金进行现金管理的公告》(公告编号：临2025-034)。 证券代码：600648、900912 证券简称：外高桥、外高B股 公告编号：临2025-052 上海外高桥集团股份公司 关于使用闲置募集资金进行现金管理赎回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 2025年12月16日 证券代码：600648，9009 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603906 证券简称：龙蟠科技 公告编号：2025-137 江苏龙蟠科技集团股份有限公司 关于使用闲置募集资金购买理财产品的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 基本情况 ■ ● 已履行的审议程序 江苏龙蟠科技集团股份有限公司（以下简称"公司"）于2025年3月28日召开第四届董事会第三十四次会 议与第四届监事会第二十六次会议，审议通过了《关于公司使用部分闲置募集资金进行现金管理的议 案》，公司（含下属公司）拟使用闲置非公开发行股票募集资金不超过人民币6亿元进行现金管理。 ● 特别风险提示 尽管公司投资安全性高、流动性好的现金管理产品，总体风险可控，但金融市场受宏观经济的影响较 大，不排除该项投资受到市场波动的影响，存在一定的系统性风险。公司将根据经济形势以及金融市场 的变化适时适量地介入，降低市场波动引起的投资风险。 一、前次理财产品到期赎回的情况 ■ 注：序号1和序号2理财内容详见公司于2025年8月8日在上海证券交易所网 ...

Core Viewpoint - The company plans to use idle raised funds amounting to 168 million yuan for cash management through financial products, aiming to enhance fund utilization efficiency and shareholder returns while ensuring that the main investment projects remain unaffected [1][2][3]. Investment Overview - **Investment Amount**: The total amount for the financial products is 168 million yuan [1][3]. - **Source of Funds**: The funds are sourced from temporarily idle raised funds from a non-public stock issuance, totaling approximately 2.2 billion yuan after deducting issuance costs [3][4]. - **Investment Purpose**: The cash management aims to maximize shareholder interests by improving the efficiency and returns of idle funds without impacting the main investment projects [2][8]. Investment Details - **Investment Types**: The company is investing in bank wealth management products, which are characterized as principal-protected and floating return products [5][6]. - **Investment Duration**: The investment periods for the financial products range from 47 to 60 days, with specific start and end dates for each product [6][8]. - **Expected Returns**: The expected annualized returns for the products vary, with some products offering rates around 0.6% to 2.4% [5][6]. Financial Impact - **Recent Financial Metrics**: As of June 30, 2025, the company's total assets were approximately 17.84 billion yuan, with a net asset value of about 3.1 billion yuan [8][9]. - **Debt Ratio**: The company's debt ratio stood at 78.41%, and the investment in financial products represents 5.25% of the company's cash holdings [9]. - **Effect on Operations**: The cash management initiative is not expected to adversely affect the company's main business operations or financial health, as it is designed to enhance fund efficiency while maintaining operational liquidity [8][9].

Core Viewpoint - The company, Shengda Biology, announced the use of idle raised funds for cash management, indicating a strategic move to enhance liquidity and yield on its financial resources [1] Group 1: Financial Management - Shengda Biology and its subsidiaries will utilize up to RMB 23,000.00 million of temporarily idle raised funds for cash management [1] - The total amount for this cash management initiative is RMB 5,000.00 million, which will be invested in structured deposit products from the Bank of China [1] - The expected annualized yield for the investment ranges from 0.60% to 1.80%, with a product duration of 32 days [1]